LB Pharmaceuticals Inc (NASDAQ:LBRX) IPO
IPO
Priced at US$15.00 a share on Sep 10, 2025.
- Price
- US$15.00 a share
- Shares offered
- 19,000,000 shares of common stock
- Offering size
- US$285 million
- Underwriters' option
- Up to 2,850,000 more shares
- Listing
- LBRX on the Nasdaq Global Market
- Underwriters
- Leerink Partners, Piper Sandler, Stifel · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | May 20, 2024 |
| Filed publicly | Aug 22, 2025 |
| Amended once | Sep 8, 2025 |
| Shares registered with an exchange | Sep 9, 2025 |
| Declared effective by the SEC | Sep 10, 2025 |
| Final prospectus, with the price | Sep 12, 2025 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 12, 2025 |
| EFFECT · Notice that a registration is effective | Sep 10, 2025 |
| S-1MEF · Registration of more shares for the same offering | Sep 10, 2025 |
| CERT · Exchange's certificate of listing | Sep 10, 2025 |
| CORRESP · Letter to the SEC | Sep 9, 2025 |
| CORRESP · Letter to the SEC | Sep 9, 2025 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 9, 2025 |
| S-1/A · Registration statement, amended | Sep 8, 2025 |
| CORRESP · Letter to the SEC | Sep 3, 2025 |
| CORRESP · Letter to the SEC | Aug 22, 2025 |
| S-1 · Registration statement | Aug 22, 2025 |
| UPLOAD · Letter from the SEC | Aug 12, 2025 |
| DRSLTR · Letter to the SEC with a draft | Jul 23, 2025 |
| DRS/A · Draft registration statement, amended | Jul 23, 2025 |
| UPLOAD · Letter from the SEC | Jul 2, 2024 |
| DRSLTR · Letter to the SEC with a draft | Jun 24, 2024 |
| DRS/A · Draft registration statement, amended | Jun 24, 2024 |
| UPLOAD · Letter from the SEC | Jun 17, 2024 |
| DRS · Draft registration statement | May 20, 2024 |
From the cover of the final prospectus (424B4) filed Sep 12, 2025